145 related articles for article (PubMed ID: 36137638)
1. Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial.
Nørgaard-Pedersen C; Nielsen K; Steffensen R; Eriksen L; Jørgensen MM; Kesmodel US; Christiansen OB
BMJ Open; 2022 Sep; 12(9):e064780. PubMed ID: 36137638
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
[TBL] [Abstract][Full Text] [Related]
3. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation.
Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Atik RB; Bloemenkamp KW; Brady R; Briley A; Cavallaro R; Cheong YC; Chu J; Eapen A; Essex H; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Parrott S; Ross JA; Sharpe L; Stewart J; Trépel D; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
Health Technol Assess; 2016 May; 20(41):1-92. PubMed ID: 27225013
[TBL] [Abstract][Full Text] [Related]
4. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?
Egerup P; Kolte AM; Larsen EC; Krog M; Nielsen HS; Christiansen OB
Hum Reprod; 2016 Nov; 31(11):2428-2434. PubMed ID: 27591241
[TBL] [Abstract][Full Text] [Related]
5. Preconceptual administration of doxycycline in women with recurrent miscarriage and chronic endometritis: protocol for the Chronic Endometritis and Recurrent Miscarriage (CERM) trial, a multicentre, double-blind, placebo-controlled, adaptive randomised trial with an embedded translational substudy.
Odendaal J; Black N; Bouliotis G; Guck J; Underwood M; Fisher J; Quenby S
BMJ Open; 2023 Dec; 13(12):e081470. PubMed ID: 38040426
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial.
Stephenson MD; Dreher K; Houlihan E; Wu V
Am J Reprod Immunol; 1998 Feb; 39(2):82-8. PubMed ID: 9506206
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial.
Stephenson MD; Kutteh WH; Purkiss S; Librach C; Schultz P; Houlihan E; Liao C
Hum Reprod; 2010 Sep; 25(9):2203-9. PubMed ID: 20634190
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial.
Yamada H; Deguchi M; Saito S; Takeshita T; Mitsui M; Saito T; Nagamatsu T; Takakuwa K; Nakatsuka M; Yoneda S; Egashira K; Tachibana M; Matsubara K; Honda R; Fukui A; Tanaka K; Sengoku K; Endo T; Yata H
EClinicalMedicine; 2022 Aug; 50():101527. PubMed ID: 35795714
[TBL] [Abstract][Full Text] [Related]
10. Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium.
Tang AW; Alfirevic Z; Turner MA; Drury J; Quenby S
Trials; 2009 Nov; 10():102. PubMed ID: 19903335
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial.
Christiansen OB; Larsen EC; Egerup P; Lunoee L; Egestad L; Nielsen HS
BJOG; 2015 Mar; 122(4):500-8. PubMed ID: 25412569
[TBL] [Abstract][Full Text] [Related]
13. High doses of intravenous immunoglobulin stimulate regulatory T cell and suppress natural killer cell in women with recurrent pregnancy loss.
Yamada H; Deguchi M; Saito S; Takeshita T; Mitsui M; Saito T; Nagamatsu T; Takakuwa K; Nakatsuka M; Yoneda S; Egashira K; Tachibana M; Matsubara K; Honda R; Fukui A; Tanaka K; Sengoku K; Endo T; Yata H
J Reprod Immunol; 2023 Aug; 158():103977. PubMed ID: 37354783
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study.
Pasquier E; de Saint-Martin L; Marhic G; Chauleur C; Bohec C; Bretelle F; Lejeune-Saada V; Hannigsberg J; Plu-Bureau G; Cogulet V; Merviel P; Mottier D
BMJ Open; 2019 Mar; 9(3):e025649. PubMed ID: 30898821
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the role of paternal factors in aetiology and prognosis of recurrent pregnancy loss: study protocol for a hospital-based multicentre case-control study and cohort study (REMI III project).
du Fossé N; van der Hoorn ML; Eikmans M; Heidt S; le Cessie S; Mulders A; van Lith J; Lashley E
BMJ Open; 2019 Nov; 9(11):e033095. PubMed ID: 31727666
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
[TBL] [Abstract][Full Text] [Related]
17. Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment.
Sung N; Khan SA; Yiu ME; Jubiz G; Salazar MD; Skariah A; Dambaeva S; Kwak-Kim J
J Reprod Immunol; 2021 Nov; 148():103369. PubMed ID: 34492567
[TBL] [Abstract][Full Text] [Related]
18. A systemic review of intravenous immunoglobulin G treatment in women with recurrent implantation failures and recurrent pregnancy losses.
Saab W; Seshadri S; Huang C; Alsubki L; Sung N; Kwak-Kim J
Am J Reprod Immunol; 2021 Apr; 85(4):e13395. PubMed ID: 33511656
[TBL] [Abstract][Full Text] [Related]
19. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study.
Jablonowska B; Selbing A; Palfi M; Ernerudh J; Kjellberg S; Lindton B
Hum Reprod; 1999 Mar; 14(3):838-41. PubMed ID: 10221723
[TBL] [Abstract][Full Text] [Related]
20. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
Sapir T; Carp H; Shoenfeld Y
Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
